Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2026-02-10 @ 1:10 AM
Study NCT ID:
NCT06410651
Status:
RECRUITING
Last Update Posted:
2024-05-13
First Post:
2024-05-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma
Sponsor:
Organization: